JP2711983B2 - Disinfection tablets - Google Patents
Disinfection tabletsInfo
- Publication number
- JP2711983B2 JP2711983B2 JP23539393A JP23539393A JP2711983B2 JP 2711983 B2 JP2711983 B2 JP 2711983B2 JP 23539393 A JP23539393 A JP 23539393A JP 23539393 A JP23539393 A JP 23539393A JP 2711983 B2 JP2711983 B2 JP 2711983B2
- Authority
- JP
- Japan
- Prior art keywords
- tablet
- water
- tica
- weight
- calcium carbonate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Agricultural Chemicals And Associated Chemicals (AREA)
Description
【0001】[0001]
【産業上の利用分野】本発明はトリクロルイソシアヌル
酸(以下、TICAという)と粒状炭酸カルシウムを配
合し成形した殺菌消毒用錠剤に関するものであり、水と
接触した際に膨潤あるいは崩壊せずに、その表面から徐
々に溶解し、且つ処理水のpHを低下させない殺菌消毒
用錠剤を提供するものである。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a tablet for disinfecting and disinfecting formed by mixing trichloroisocyanuric acid (hereinafter referred to as TICA) and granular calcium carbonate, and does not swell or disintegrate when contacted with water. An object of the present invention is to provide a disinfecting tablet which gradually dissolves from its surface and does not lower the pH of treated water.
【0002】[0002]
【従来の技術】プール水などの循環水系あるいは貯水な
どの閉鎖水系において使用される活性塩素を放出する固
形薬剤としては、高度サラシ粉や塩素化イソシアヌル酸
系化合物がある。これらのうち特にTICAは活性塩素
含有量が高く、水中に投入した際に完溶して不溶解物を
発生せず、また保存時の安定性に優れていることなどか
ら汎用されている。2. Description of the Related Art Solid chemicals that release active chlorine used in a circulating water system such as pool water or a closed water system such as water storage include advanced salad powder and chlorinated isocyanuric acid compounds. Among them, TICA is particularly widely used because it has a high active chlorine content, is completely dissolved when put into water, does not generate insolubles, and has excellent storage stability.
【0003】しかしながら、TICAは常温において溶
解度が比較的小さく、これを打錠成形したものはさらに
溶解性が悪くなるので、所期の活性塩素濃度を維持し難
く、急激な処理水の汚染が起こった場合には、十分な殺
菌消毒が行えないなどの問題があった。またプールなど
の循環水系あるいは貯水などの閉鎖水系において使用す
る場合には、活性塩素の分解によって塩酸を生じ、これ
が蓄積して処理水のpHを低下させ、配管や容器を腐
食、劣化させるなどのトラブルを引き起こす原因となっ
ていた。[0003] However, TICA has relatively low solubility at room temperature, and its tablet-compacted one has further poor solubility, so that it is difficult to maintain the expected active chlorine concentration, and sudden contamination of treated water occurs. In such a case, there is a problem that sufficient sterilization cannot be performed. When used in a circulating water system such as a pool or in a closed water system such as a reservoir, hydrochloric acid is generated by the decomposition of active chlorine, which accumulates and lowers the pH of treated water, causing corrosion and deterioration of piping and containers. It was causing trouble.
【0004】これらの問題点を解決する提案がいくつか
なされている。例えば固形薬剤の溶解速度を改善する提
案として、特開平5−43407号公報には溶解度の高
いジクロルイソシアヌル酸塩水和物の錠剤を用いる方
法、特開昭51−139628号公報にはジクロルイソ
シアヌル酸ナトリウムの錠剤を用いる方法、また特開昭
58−59904号公報にはTICA、シアヌル酸及び
アルカリ金属塩またはアルカリ土類金属酸化物からなる
錠剤、さらに特開平1−128905号公報にはTIC
Aとオルトほう酸を混合して加圧成形した錠剤が開示さ
れている。Some proposals have been made to solve these problems. For example, as a proposal for improving the dissolution rate of a solid drug, Japanese Patent Application Laid-Open No. 5-43407 discloses a method using tablets of dichlorisocyanurate hydrate having high solubility, and Japanese Patent Application Laid-Open No. 51-139628 discloses a method using dichloroisocyanur. JP-A-58-59904 discloses a method of using a tablet comprising TICA, cyanuric acid and an alkali metal salt or an alkaline earth metal oxide, and JP-A-1-128905 discloses a method using a TIC.
A tablet is disclosed which is obtained by mixing A with orthoboric acid and pressing the mixture.
【0005】他方処理水の酸性化を防止するためには、
特開昭59−67208号公報にはTICA、イソシア
ヌル酸及びマグネシウム塩またはカルシウム塩を配合し
た錠剤、特開平1−132504号公報にはジクロルイ
ソシアヌル酸ナトリウムまたはその水和物に酸化マグネ
シウム、水酸化マグネシウム、水酸化カルシウム及び炭
酸ナトリウムからなるアルカリ化合物の1種またはそれ
以上を混合し加圧成形した錠剤が提案されている。On the other hand, in order to prevent acidification of treated water,
JP-A-59-67208 discloses a tablet containing TICA, isocyanuric acid and a magnesium salt or a calcium salt, and JP-A-1-132504 discloses a tablet prepared by adding sodium dichlorisocyanurate or a hydrate thereof to magnesium oxide, hydroxide. There has been proposed a tablet obtained by mixing and pressing one or more kinds of alkali compounds consisting of magnesium, calcium hydroxide and sodium carbonate.
【0006】さらに循環水系あるいは閉鎖水系における
pH低下を防止する方法として、特開昭58−2055
81号公報には、アルカリ土類金属の水酸化物、炭酸塩
及び塩基性炭酸塩の一種または二種以上の混合物を成型
した薬剤をプール水に接触させる方法が提案されてい
る。Further, as a method for preventing a pH decrease in a circulating water system or a closed water system, JP-A-58-2055 has been proposed.
No. 81 proposes a method in which an agent formed by molding one or a mixture of two or more of hydroxides, carbonates and basic carbonates of alkaline earth metals is brought into contact with pool water.
【0007】[0007]
【発明が解決しようとする課題】ジクロルイソシアヌル
酸塩あるいはその水和物を有効成分とする錠剤は、高温
における保存安定性が十分でなく、使用条件によっては
錠剤が崩壊あるいは膨潤する欠陥があった。TICAに
シアヌル酸とアルカリ金属塩またはオルトほう酸を組み
合わせて打錠成形したものを用いた場合は、TICAの
含有量が低下し多量の錠剤の使用を必要とし、また処理
水中にほう素、りん系の化合物が残存する問題があっ
た。Tablets containing dichloroisocyanurate or a hydrate thereof as an active ingredient do not have sufficient storage stability at high temperatures and have a defect that the tablet may be disintegrated or swelled depending on use conditions. Was. When TICA is used in the form of a tablet formed by combining cyanuric acid with an alkali metal salt or orthoboric acid, the content of TICA decreases and a large number of tablets must be used. There was a problem that the compound of No. remained.
【0008】本発明の目的は、プール水などの循環水系
あるいは貯水などの閉鎖水系で繰り返し使用しても処理
水のPH低下が少なく、錠剤が表面から適当な速さで溶
解し、保存安定性にも優れているTICAの組成物錠剤
を提供するものである。[0008] An object of the present invention is to reduce the pH of treated water even when repeatedly used in a circulating water system such as pool water or a closed water system such as water storage, dissolve tablets at an appropriate speed from the surface, and preserve the storage stability. It is intended to provide a composition tablet of TICA which is excellent in the above.
【0009】[0009]
【課題を解決するための手段】本発明者等は、このよう
な事情に鑑み検討を重ねた結果、TICA100重量部
に対して、90%以上が粒径0.2〜3mmの範囲にあ
る炭酸カルシウム5〜70重量部を配合した組成物を加
圧成形することによって、所期の目的を達成できる錠剤
が得られることを見い出し、本発明を完遂するに至っ
た。Means for Solving the Problems The inventors of the present invention have repeatedly studied in view of such circumstances, and as a result, have obtained 100 parts by weight of TICA.
In contrast, 90% or more is in the range of particle size of 0.2 to 3 mm.
That by pressure-molding a composition containing the calcium carbonated 5-70 parts by weight, found that tablets capable of attaining the intended purpose can be obtained, thus leading to complete the present invention.
【0010】本発明の実施において用いられるTICA
は、粉体または顆粒状のいずれの形状でもよいが、打錠
時の取扱いを考慮すれば顆粒状のものが好ましい。また
本発明の実施において用いられる炭酸カルシウムとして
は、90%以上の粒子が径0.2〜3mmの範囲にあるも
のであり、特に寒水石を粒子径0.5〜2mmの範囲に粉
砕したものが好適である。[0010] TICA used in the practice of the present invention
May be in the form of powder or granules, but granules are preferred in consideration of handling during tableting. In addition, as the calcium carbonate used in the practice of the present invention, 90% or more of the particles are those having a diameter of 0.2 to 3 mm, and particularly those obtained by pulverizing cold water stone to a particle diameter of 0.5 to 2 mm. Is preferred.
【0011】粒子径が0.2mmより小さい炭酸カルシ
ウムを用いた場合は溶解速度が早過ぎるので、TICA
より先に溶解して錠剤が水中で崩壊するおそれがある。
また逆に、炭酸カルシウムの粒子径が3mmを超えるも
のを用いた場合は、TICAと均一に配合し難く、且つ
炭酸カルシウム粒子が水中に不溶分として残るので、好
ましくない。従って、原料として使用する炭酸カルシウ
ム中に粒径が0.2mm未満あるいは3mmを超えるも
のが10%を超えて含まれると、前記のトラブルが顕著
に発生する。 When calcium carbonate having a particle size of less than 0.2 mm is used, the dissolution rate is too high.
The tablet may dissolve earlier and disintegrate in water.
Conversely, when calcium carbonate having a particle diameter of more than 3 mm is used, it is difficult to uniformly mix it with TICA, and calcium carbonate particles remain insoluble in water, which is not preferable. Therefore, calcium carbonate used as a raw material
The particle size is less than 0.2mm or more than 3mm
If more than 10% is contained, the above trouble is remarkable.
Occurs.
【0012】なお、炭酸カルシウムの代わりに炭酸ソー
ダあるいは水酸化カルシウムなどを用いた場合は、これ
らがTICAより溶解し易いため、錠剤を水中に投入し
た場合に崩壊し易く、また貯蔵時の保存安定性も低下す
るので、実用に適さない。When sodium carbonate or calcium hydroxide is used in place of calcium carbonate, these are more easily dissolved than TICA, so that they are easily disintegrated when tablets are put in water, and are stable during storage. It is not suitable for practical use because its properties are reduced.
【0013】本発明の殺菌消毒用錠剤のTICAと炭酸
カルシウムの配合比は、TICA100重量部に対し
て、炭酸カルシウムが5〜70重量部、好ましくは10
〜50重量部の範囲である。TICAに対する炭酸カル
シウムの配合比が5重量部未満になれば、処理水のpH
低下を防止する機能が劣り、70重量部を超えると錠剤
の溶解速度が早くなり過ぎ、且つ保存安定性が低下する
ので好ましくない。The mixing ratio of TICA to calcium carbonate in the tablet for sterilization and disinfection of the present invention is such that calcium carbonate is 5 to 70 parts by weight, preferably 10 to 100 parts by weight of TICA.
The range is from 50 to 50 parts by weight. If the mixing ratio of calcium carbonate to TICA is less than 5 parts by weight, the pH of the treated water
The function of preventing the decrease is inferior, and if it exceeds 70 parts by weight, the dissolution rate of the tablet becomes too fast, and the storage stability is undesirably reduced.
【0014】本発明の殺菌消毒用錠剤の製造に当たって
は、一般的に用いられている乾式混合機と打錠機を使用
することができ、錠剤の滑性を良くするために微量のス
テアリン酸塩などを混合したのち打錠しても差し支えな
い。In producing the tablet for sterilization and disinfection of the present invention, a commonly used dry blender and tableting machine can be used, and a small amount of stearate is used to improve the lubricity of the tablet. Tablets can be mixed after mixing them.
【0015】[0015]
【作用】本発明の殺菌消毒用錠剤は、水と接触させた際
に錠剤表面のTICAが徐々に溶解し、活性塩素を発生
させる。この活性塩素は最終的に塩酸に変化するが、こ
の塩酸は錠剤に含まれる炭酸カルシウムと反応して塩化
カルシウムに変化するので、処理水のpH低下が抑制さ
れる。本発明によれば、炭酸カルシウムの大きさを粒子
径0.2〜3mmの範囲とし、且つTICA100重量部
に対して炭酸カルシウムを5〜70重量部の割合で配合
しているため、炭酸カルシウムのほとんどが塩酸と反応
し、錠剤中のすべての成分を完溶させることができる。
本発明を実施例及び比較例により、具体的に説明する。The tablet for disinfection and disinfection of the present invention, when brought into contact with water, gradually dissolves the TICA on the tablet surface to generate active chlorine. This active chlorine finally changes into hydrochloric acid, but this hydrochloric acid reacts with calcium carbonate contained in the tablet and changes into calcium chloride, so that a decrease in pH of the treated water is suppressed. According to the present invention, the size of calcium carbonate is in the range of 0.2 to 3 mm in particle size, and calcium carbonate is blended in a ratio of 5 to 70 parts by weight with respect to 100 parts by weight of TICA. Most react with hydrochloric acid and can completely dissolve all ingredients in the tablet.
The present invention will be specifically described with reference to Examples and Comparative Examples.
【0016】[0016]
(実施例1〜5及び比較例1〜6)顆粒状のTICA1
00重量部に、表1に示すとおりの粒子径を有する炭酸
カルシウム及び滑剤としてのステアリン酸マグネシウム
を夫々の配合割合で均一に混合する。得られた混合物を
直径50mmの金型を有する連続打錠機を用い、面圧5
00kg/cm2 の打錠条件で加圧成形して重さ100
gの円柱状錠剤を得た。(Examples 1 to 5 and Comparative Examples 1 to 6) Granular TICA1
To 00 parts by weight, calcium carbonate having a particle size as shown in Table 1 and magnesium stearate as a lubricant are uniformly mixed at respective mixing ratios. Using a continuous tableting machine having a mold of 50 mm in diameter,
Press molding under tableting conditions of 00 kg / cm 2 and weigh 100
g of columnar tablets were obtained.
【0017】前記の円柱状錠剤を乳鉢を用いて粉砕し、
有効塩素含有量を測定すると共に、この粉砕物をM−ア
ルカリ度55mg/リットル、pH7.4である水道水
50リットルを入れた容器中に投入し、有効塩素濃度が
135mg/リットルになるように溶液を調製した。こ
の容器の蓋を緩く閉めて屋外に1週間静置し、次いでオ
ゾンガスを容器中に吹き込み、残留する有効塩素を分解
したのち、液のpHを測定した。水道水に投入した錠剤
の粉砕物量、静置後の有効塩素含有量及びpH測定値
は、表2に示すとおりであった。The above-mentioned cylindrical tablet is crushed using a mortar,
While measuring the available chlorine content, this pulverized product was put into a container containing 50 liters of tap water having an M-alkalinity of 55 mg / liter and pH 7.4 so that the available chlorine concentration became 135 mg / liter. A solution was prepared. The lid of this container was loosely closed and allowed to stand outdoors for one week, and then ozone gas was blown into the container to decompose the remaining available chlorine, and then the pH of the solution was measured. The amount of the crushed tablet, the effective chlorine content after standing, and the measured pH value of the tablet charged in tap water were as shown in Table 2.
【0018】[0018]
【表1】 [Table 1]
【0019】[0019]
【表2】 [Table 2]
【0020】68リットルの水を入れたプラスチック製
水槽(水深27cm)の中央部(水深10cm)に金網
を置き、この金網上に予め重量を測定した錠剤1錠を載
せて2日間静置したのち、錠剤を取り出して重量を測定
し、この試験前後における錠剤重量の測定値から減少率
を求めた。また、取り出した時の錠剤及び水槽底部の状
態を目視にて観察した。その結果は表3に示すとおりで
あった。A wire mesh is placed at the center (water depth 10 cm) of a plastic water tank (water depth 27 cm) containing 68 liters of water, and one tablet weighed in advance is placed on the wire mesh and allowed to stand for 2 days. The tablets were taken out, the weight was measured, and the reduction rate was determined from the measured values of the tablet weight before and after this test. The state of the tablets and the bottom of the water tank at the time of removal was visually observed. The results were as shown in Table 3.
【0021】[0021]
【表3】 [Table 3]
【0022】[0022]
【発明の効果】本発明の殺菌消毒用錠剤は、水中に投入
した際に崩壊あるいは膨潤することなく徐々に表面より
溶解し、長時間にわたって活性塩素を供給することがで
き、且つ長時間経過したのちも処理水のpHを低下させ
ないので、水泳プール水、浄化槽排水及び各種廃水の殺
菌消毒用として極めて有用である。The tablet for disinfection and disinfection of the present invention dissolves gradually from the surface without disintegration or swelling when put into water, can supply active chlorine for a long time, and has passed for a long time. Since it does not lower the pH of the treated water later, it is extremely useful for disinfection of swimming pool water, septic tank drainage and various wastewater.
Claims (1)
部に対して、90%以上が粒径0.2〜3mmの範囲に
ある炭酸カルシウム5〜70重量部を配合した組成物を
加圧成形したことを特徴とする殺菌消毒用錠剤。 Respect 1. A 100 parts by weight of trichloro isocyanuric acid, pressurizing the composition more than 90% was blended 5 to 70 parts by weight carbonated calcium <br/> Ru Ah in the range of particle sizes 0.2~3mm A tablet for sterilization and disinfection characterized by being formed by compression.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP23539393A JP2711983B2 (en) | 1993-08-27 | 1993-08-27 | Disinfection tablets |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP23539393A JP2711983B2 (en) | 1993-08-27 | 1993-08-27 | Disinfection tablets |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH0769813A JPH0769813A (en) | 1995-03-14 |
JP2711983B2 true JP2711983B2 (en) | 1998-02-10 |
Family
ID=16985428
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP23539393A Expired - Fee Related JP2711983B2 (en) | 1993-08-27 | 1993-08-27 | Disinfection tablets |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2711983B2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4356970B2 (en) | 2002-09-12 | 2009-11-04 | 四国化成工業株式会社 | Fast-soluble chlorinated isocyanuric acid moldings |
-
1993
- 1993-08-27 JP JP23539393A patent/JP2711983B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JPH0769813A (en) | 1995-03-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4692335A (en) | Calcium hypochlorite tablet | |
JP7376531B2 (en) | Low solubility hypochlorite-containing tablets | |
JP4549962B2 (en) | Foamable solid flocculant for water treatment | |
AU781655B2 (en) | Stable, high available halogen 1,3,5-triazine-2,4,6-trione compositions having rapid dissolution rates | |
JP2711983B2 (en) | Disinfection tablets | |
JPH0827119A (en) | Dimethylhydantoin halide-based formed article | |
JP4356970B2 (en) | Fast-soluble chlorinated isocyanuric acid moldings | |
JP2009214090A (en) | Method for producing solid buffer | |
JP2643199B2 (en) | Chloroisocyanurate composition | |
JPH0472804B2 (en) | ||
JP3063272B2 (en) | Fast soluble chlorinated isocyanuric acid molded article | |
JP2005041813A (en) | Halogenated hydantoin molding | |
JP2003160405A (en) | Rapidly soluble chlorinated isocyanuric acid formed material | |
JPS642563B2 (en) | ||
JP3816966B2 (en) | Chlorinated isocyanuric acid molding | |
US20040046149A1 (en) | Quatrepolymer tablet | |
JPH08231314A (en) | Chlorinated isocyanuric acid molding | |
JP4925245B2 (en) | Halogenated hydantoin moldings | |
US20050266097A1 (en) | Quatrepolymer Tablet | |
WO2003032733A1 (en) | Composition for controlling the dissolving rate of solid sanitizers | |
JPH0118903B2 (en) | ||
JPS5951948B2 (en) | Rapidly disintegrating chlorinated isocyanuric acid molded product in water | |
JPS62123103A (en) | Calcium hypochlorite tablet for water sanitation | |
MXPA00009525A (en) | Stable, high available halogen 1,3,5-triazine-2,4,6-trione compositions having rapid dissolution rates |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 11 Free format text: PAYMENT UNTIL: 20081031 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 12 Free format text: PAYMENT UNTIL: 20091031 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091031 Year of fee payment: 12 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 13 Free format text: PAYMENT UNTIL: 20101031 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 13 Free format text: PAYMENT UNTIL: 20101031 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 14 Free format text: PAYMENT UNTIL: 20111031 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20121031 Year of fee payment: 15 |
|
LAPS | Cancellation because of no payment of annual fees |